LRRK2
LRRK2 inhibitors are compounds that target and inhibit the activity of Leucine-Rich Repeat Kinase 2 (LRRK2), an enzyme involved in several cellular processes, including autophagy, vesicle trafficking, and inflammation. Mutations in the LRRK2 gene are associated with an increased risk of developing Parkinson's disease, making LRRK2 a significant target for neurodegenerative disease research. Inhibitors of LRRK2 are crucial for exploring its role in Parkinson's disease and for developing potential therapeutic strategies. At CymitQuimica, we offer a selection of LRRK2 inhibitors to support your research in neurodegeneration, kinase signaling, and therapeutic development.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CCG-1423 REF: TM-T2014CAS: 285986-88-1 | 99.98% | 38.00 €~646.00 € | Mon 16 Dec 24 | |
LRRK2-IN-10 REF: TM-T79746CAS: 2704562-80-9 | 98% | 907.00 €~2,337.00 € | Mon 27 Jan 25 | |
LRRK2-IN-7 REF: TM-T73176CAS: 2307277-93-4 | 99.26% | 226.00 €~1,869.00 € | Mon 27 Jan 25 |
CCG-1423
Ref: TM-T2014
5mg | 38.00 € | ||
10mg | 56.00 € | ||
25mg | 94.00 € | ||
50mg | 159.00 € | ||
100mg | 256.00 € | ||
200mg | 399.00 € | ||
500mg | 646.00 € | ||
1mL*10mM (DMSO) | 55.00 € |
LRRK2-IN-10
Ref: TM-T79746
25mg | 1,410.00 € | ||
50mg | 1,851.00 € | ||
100mg | 2,337.00 € |
LRRK2-IN-7
Ref: TM-T73176
1mg | 226.00 € | ||
5mg | 563.00 € | ||
10mg | 900.00 € | ||
25mg | 1,435.00 € | ||
50mg | 1,869.00 € |